NYSE:EHAB Enhabit (EHAB) Stock Price, News & Analysis $13.80 0.00 (0.00%) Closing price 05/14/2026Extended Trading$13.80 0.00 (0.00%) As of 05/14/2026 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Enhabit Stock (NYSE:EHAB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Enhabit alerts:Sign Up Key Stats Today's Range$13.79▼$13.8150-Day Range$13.61▼$14.0852-Week Range$6.47▼$14.22Volume1.38 million shsAverage Volume1.05 million shsMarket Capitalization$706.97 millionP/E RatioN/ADividend YieldN/APrice Target$13.57Consensus RatingHold Company Overview Enhabit, Inc. (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience. The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services. Enhabit’s clinical teams work closely with primary care physicians, hospitals and other care providers to execute tailored care plans, monitor patient progress and adjust treatments as needed. Leveraging proprietary care-management technology, Enhabit aims to streamline clinical workflows, improve care coordination and reduce avoidable hospital readmissions. Enhabit operates across more than 20 states in both urban and rural markets, having expanded its footprint through a combination of organic growth and strategic acquisitions of regional home health and hospice providers. The company’s leadership team comprises seasoned healthcare executives with decades of experience in home health, hospice and care management. With an emphasis on quality, compliance and patient satisfaction, Enhabit continues to pursue opportunities that strengthen its service capabilities and extend its reach to communities nationwide. AI Generated. May Contain Errors. Read More Enhabit Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScoreEHAB MarketRank™: Enhabit scored higher than 51% of companies evaluated by MarketBeat, and ranked 501st out of 858 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingEnhabit has received a consensus rating of Hold. The company's average rating score is 2.11, and is based on no strong buy ratings, 2 buy ratings, 6 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Enhabit is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageEnhabit has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Enhabit's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.34% Earnings GrowthEarnings for Enhabit are expected to grow by 10.34% in the coming year, from $0.58 to $0.64 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Enhabit is -153.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Enhabit is -153.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEnhabit has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Enhabit's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.43% of the float of Enhabit has been sold short.Short Interest Ratio / Days to CoverEnhabit has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Enhabit has recently decreased by 11.82%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEnhabit does not currently pay a dividend.Dividend GrowthEnhabit does not have a long track record of dividend growth. News and Social Media3.3 / 5News Sentiment0.25 News SentimentEnhabit has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Enhabit this week, compared to 1 article on an average week.Search Interest1 people have searched for EHAB on MarketBeat in the last 30 days. MarketBeat Follows3 people have added Enhabit to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Enhabit insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $57,163.00 in company stock.Percentage Held by Insiders3.40% of the stock of Enhabit is held by insiders.Percentage Held by InstitutionsEnhabit has minimal institutional ownership at this time.Read more about Enhabit's insider trading history. Receive EHAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EHAB Stock News HeadlinesEnhabit Home Health & Hospice Announces New Chief Executive OfficerMay 18, 2026 | businesswire.comEnhabit, Inc. (NYSE:EHAB) Receives Consensus Rating of "Hold" from AnalystsMay 18, 2026 | americanbankingnews.comHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall of Fame Trader Jon Najarian now says EVERYONE is missing an even bigger story about the SpaceX IPO… That it's just the start of an Elon Musk $44 trillion "Superconvergence…" An event that could kick off as soon as June 12th.May 22 at 1:00 AM | Banyan Hill Publishing (Ad)Comparing Enhabit (NYSE:EHAB) and Cencora (NYSE:COR)May 13, 2026 | americanbankingnews.comEnhabit Shareholders Approve Merger and Transition to PrivateMay 12, 2026 | tipranks.comEnhabit Faces Shareholder Suits Over Kinderhook Take-Private DealMay 5, 2026 | tipranks.comHow The Enhabit (EHAB) Narrative Is Resetting Around Kinderhook’s US$13.80 Cash OfferApril 26, 2026 | finance.yahoo.comEnhabit Advances Kinderhook Acquisition With Antitrust ClearanceApril 16, 2026 | tipranks.comSee More Headlines EHAB Stock Analysis - Frequently Asked Questions How have EHAB shares performed this year? Enhabit's stock was trading at $9.22 at the beginning of 2026. Since then, EHAB shares have increased by 49.7% and is now trading at $13.80. How were Enhabit's earnings last quarter? Enhabit, Inc. (NYSE:EHAB) posted its quarterly earnings data on Thursday, May, 7th. The company reported $0.36 earnings per share for the quarter. The firm had revenue of $264.80 million for the quarter. Enhabit had a negative net margin of 0.30% and a positive trailing twelve-month return on equity of 7.24%. Who are Enhabit's major shareholders? Top institutional shareholders of Enhabit include Dimensional Fund Advisors LP (2.91%), Hsbc Holdings PLC (1.70%), Renaissance Technologies LLC (1.54%) and Capula Management Ltd (1.26%). Insiders that own company stock include Ryan Solomon, Julie Diane Jolley, Jeffrey Bolton, Stuart M Mcguigan, L Edward Shaw Jr, Erin Hoeflinger and Collin Mcquiddy. View institutional ownership trends. How do I buy shares of Enhabit? Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Enhabit own? Based on aggregate information from My MarketBeat watchlists, some other companies that Enhabit investors own include Alphabet (GOOG), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Netflix (NFLX), Home Depot (HD) and Meta Platforms (META). Company Calendar Last Earnings5/07/2026Today5/22/2026Next Earnings (Estimated)8/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 EHAB's financial health is in the Green zone, according to TradeSmith. EHAB has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNYSE:EHAB CIK1803737 Webwww.ehab.com Phone214-239-6500FaxN/AEmployees10,800Year FoundedN/APrice Target and Rating Average Price Target for Enhabit$13.57 High Price Target$14.00 Low Price Target$12.00 Potential Upside/Downside-1.7%Consensus RatingHold Rating Score (0-4)2.11 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)($0.09) Trailing P/E RatioN/A Forward P/E Ratio23.79 P/E GrowthN/ANet Income-$4.60 million Net Margins-0.30% Pretax Margin-0.13% Return on Equity7.24% Return on Assets3.48% Debt Debt-to-Equity Ratio0.70 Current Ratio1.56 Quick Ratio1.56 Sales & Book Value Annual Sales$1.06 billion Price / Sales0.67 Cash Flow$1.96 per share Price / Cash Flow7.04 Book Value$11.30 per share Price / Book1.22Miscellaneous Outstanding Shares51,230,000Free Float49,484,000Market Cap$706.97 million OptionableOptionable Beta1.26 7 Stocks to Ride The A.I. MegaboomWe are about to experience the greatest A.I. boom in stock market history... Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s. That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom. Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day. And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly... Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy. Get This Free Report This page (NYSE:EHAB) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersHow to Profit from Elon’s AI lab before it goes publicElon Musk's AI lab has partnered with the Department of Defense, Oracle, and Palantir - and he just filed conf...InvestorPlace | SponsoredMaybe the Greatest Strategy of the DecadeNate Bear, Lead Technical Tactician at Monument Traders Alliance, is going public with his highest-conviction ...Monument Traders Alliance | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredOne filing just changed the SpaceX IPO foreverSpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the larges...Behind the Markets | SponsoredSpaceX controls two-thirds of all satellites - and it is about to go publicSpaceX is targeting an IPO on June 11th, with trading set to begin June 12th and the roadshow kicking off June...NXT Wave Research | SponsoredTo Avoid 67 Million Blackouts, Trump Signs Emergency Backing of New Energy TechPresident Trump has used emergency executive powers to back a new energy technology described as 326 times mor...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
